combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma

treatment of mycosis fungoides or Sézary syndrome in adults which are subtypes of cutaneous T-cell lymphoma

"Oxysterols induce the migration of B-lymphocytes and dendritic cells to interfollicular regions of lymphoid

combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma the enhancement of apoptosis Published date November 3, 2023 Abstract " Purpose: Peripheral T-cell lymphoma HH cells, originating from an aggressive cutaneous T-cell lymphoma, were used as an experimental model Soeda , Yoshihide Kakimoto Tags Apoptosis , Bcl-2 , Brentuximab vedotin , CDC45 , Chidamide , T-cell lymphoma

GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis Here we reported the first comprehensive proteogenomic characterization of natural killer/T-cell lymphoma (NKTCL), a representative disease model to study EBV-induced lymphomagenesis, incorporating genomic, Therapeutic targeting CCR1 showed promising efficacy with EBV eradication, T-cell activation, and lymphoma Jia-Yi Chen , Li Wang , Peng-Peng Xu , Sai-Juan Chen , Wei-Li Zhao Tags CCR1 , Epstein-Barr virus , Lymphoma

As the natural ligand for EBI2 is present in blood and lymphoid tissues, the constant EBI2 activation